Pancreatic Cancer Research

ResearcherFred and Pamela Buffett Cancer CenterActive in the last 2 years

Subodh M. Lele

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3535-328X; OpenAlex author ID A5108276965. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
63
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 13

  1. NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXCL5/CXCR2 signaling axis. Co-author DOI 10.1016/j.canlet.2026.218269↗
  2. Targeting the DDX3/PAF1 axis enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218276↗
  3. Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis. Co-author DOI 10.1053/j.gastro.2023.12.018↗
  4. PAF1 cooperates with YAP1 in metaplastic ducts to promote pancreatic cancer. Co-author DOI 10.1038/s41419-022-05258-x↗
  5. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-020-01518-2↗
  6. Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis. Co-author DOI 10.1038/s41388-020-01564-w↗
  7. A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer. Co-author DOI 10.1124/jpet.118.255372↗
  8. Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. Co-author DOI 10.1053/j.gastro.2018.05.041↗
  9. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.6580↗
  10. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-2174↗
  11. Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology. Last author DOI 10.5858/arpa.2011-0229-oa↗
  12. Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis. Co-author DOI 10.1158/1078-0432.ccr-12-1789↗
  13. Pathobiological implications of MUC16 expression in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0026839↗

Closest collaborators

The 25 strongest of 63 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 12 shared papers, 2011–2026 · strength 1.30
  2. Moorthy Palanimuthu Ponnusamy · 8 shared papers, 2011–2026 · strength 0.92
  3. Sanchita Rauth · 6 shared papers, 2018–2026 · strength 0.85
  4. Palanisamy Nallasamy · 5 shared papers, 2021–2026 · strength 0.78
  5. Jesse L. Cox · 3 shared papers, 2022–2026 · strength 0.58
  6. Rama Krishna Nimmakayala · 5 shared papers, 2018–2024 · strength 0.58
  7. Kavita B. Mallya · 4 shared papers, 2014–2026 · strength 0.50
  8. Imayavaramban Lakshmanan · 5 shared papers, 2011–2026 · strength 0.45
  9. Zahraa Wajih Alsafwani · 2 shared papers, 2024–2026 · strength 0.44
  10. Parthasarathy Seshacharyulu · 3 shared papers, 2018–2026 · strength 0.43
  11. Satyanarayana Rachagani · 7 shared papers, 2011–2021 · strength 0.41
  12. Venkatesh Varadharaj · 2 shared papers, 2022–2026 · strength 0.40
  13. Saravanakumar Marimuthu · 2 shared papers, 2021–2026 · strength 0.36
  14. Ayoola O. Ogunleye · 2 shared papers, 2022–2024 · strength 0.31
  15. Seema C. Parte · 2 shared papers, 2022–2024 · strength 0.31
  16. Michael Anthony Hollingsworth · 5 shared papers, 2011–2021 · strength 0.28
  17. Frank Leon · 2 shared papers, 2021–2024 · strength 0.28
  18. Koelina Ganguly · 1 shared paper, 2026 · strength 0.27
  19. Sanjib Chaudhary · 1 shared paper, 2026 · strength 0.27
  20. Ramesh Pothuraju · 1 shared paper, 2026 · strength 0.27
  21. Apar Kishor Ganti · 1 shared paper, 2026 · strength 0.27
  22. Muzafar Ahmad Macha · 1 shared paper, 2026 · strength 0.27
  23. Ashu Shah · 1 shared paper, 2026 · strength 0.26
  24. Lynette M. Smith · 4 shared papers, 2014–2021 · strength 0.26
  25. Thomas C. Caffrey · 2 shared papers, 2019–2021 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.